Followers | 275 |
Posts | 56221 |
Boards Moderated | 23 |
Alias Born | 08/29/2007 |
Sunday, July 23, 2023 3:49:16 PM
GoSymbol lookup
Health Care : Life Sciences Tools & Services | Small Cap BlendCompany profile
Codexis, Inc. is an enzyme engineering company. The Company is engaged in discovering, developing and selling enzymes and other proteins. The Company commercializes its CodeEvolver enzyme engineering technology platform and products in the manufacture of small molecule pharmaceuticals. It operates through two segments: Performance Enzymes and Novel Biotherapeutics. The Performance Enzymes segment consists primarily of two focus areas: biocatalysts for the sustainable manufacturing of pharmaceuticals, and enzymes for life science applications, including genomic sequencing and nucleic acid synthesis. The Novel Biotherapeutics segment offers product candidates include enzymes that are orally administered for function in the gastrointestinal tract (GI), such as its partnered product candidates CDX-7108 for the treatment of exocrine pancreatic insufficiency and CDX-6114 for the treatment of phenylketonuria, which are both in Phase I clinical trials.
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent CDXS News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/31/2024 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:16:02 PM
- Codexis Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/31/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2024 08:05:04 PM
- Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting • GlobeNewswire Inc. • 10/24/2024 08:05:16 PM
- Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors • GlobeNewswire Inc. • 10/22/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 08:00:52 PM
- Codexis Announces New Employment Inducement Grants • GlobeNewswire Inc. • 10/14/2024 11:05:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 10:20:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 10:20:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 10:19:58 PM
- Codexis to Report Third Quarter 2024 Financial Results on October 31 • GlobeNewswire Inc. • 10/10/2024 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 08:30:29 PM
- Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company • GlobeNewswire Inc. • 10/02/2024 08:05:32 PM
- Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences • GlobeNewswire Inc. • 10/01/2024 11:05:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 07:21:16 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/26/2024 01:27:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2024 09:19:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2024 10:16:44 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/18/2024 08:50:02 PM
- Codexis Announces New Employment Inducement Grants • GlobeNewswire Inc. • 09/06/2024 08:05:08 PM
- Codexis to Participate in Upcoming Healthcare Conferences • GlobeNewswire Inc. • 09/03/2024 08:05:58 PM
- Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting • GlobeNewswire Inc. • 08/20/2024 08:05:36 PM
- Codexis Announces New Employment Inducement Grants • GlobeNewswire Inc. • 08/16/2024 08:05:09 PM
- Codexis Publishes FY2023 Sustainability Disclosures • GlobeNewswire Inc. • 08/15/2024 08:05:22 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM